Skip to content
by Legal Desire
City

San Diego

283 announced deals involving San Diego, most recent first, with the firms that advised on each.

Most recent

SEARCH ALL 283
Latham & Watkins Advises Pelthos Therapeutics in Combination With Castle Creek Biosciences 3 Nov 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 300m 21 NAMED
Latham Advises on Aspen Neuroscience’s US$140.6 Million IPO 3 Nov 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 141m 5 NAMED
DLA Piper advises AI-native specialty insurance platform Ledgebrook on primary equity financing 28 Oct 2026
Capital Markets & IPO Financial Services DLA Piper USD 200m 4 NAMED
Latham Advises Guidewire on Acquisition of hyperexponential 28 Oct 2026
M&A Technology Latham & Watkins LLP USD 1.70bn 46 NAMED
Latham & Watkins Advises LSEG on US$3.535 Billion Acquisition of Octus 27 Oct 2026
M&A Financial Services Latham & Watkins LLP USD 3.54bn 66 NAMED
Latham & Watkins Advises Arcus Biosciences on US$250 Million Public Offering of Common Stock 27 Oct 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 250m 12 NAMED
Latham & Watkins Advises Melange Capital Partners as Lead Investor in EnCap’s US$3.5 Billion Minerals Continuation Vehicle 21 Oct 2026
Fund Formation Energy Latham & Watkins LLP USD 3.50bn 15 NAMED
DLA Piper advises Hyundai Transys Georgia Powertrain on US$560 million expansion 19 Oct 2026
Industrials & Manufacturing DLA Piper USD 560m 5 NAMED
DLA Piper advises POSCO International on US$550 million agreement to acquire Chord’s Marcellus gas assets 19 Oct 2026
M&A Energy DLA Piper USD 550m 14 NAMED
Latham & Watkins Advises RxSight on Collaboration With Alcon to Develop Adjustable PCIOLsLatham & Watkins Advises RxSight on Collaboration With Alcon to Develop Adjustable PCIOLs 19 Oct 2026
Joint Venture Healthcare & Life Sciences Latham & Watkins LLP 3 NAMED
Latham Advises UL Solutions on Acquisition of Eurofins Scientific’s Electrical & Electronics Business 9 Oct 2026
M&A Latham & Watkins LLP 44 NAMED
Latham Advises on Vaxcyte’s Concurrent Public Offerings of Common Stock, Pre-Funded Warrants, and Convertible Senior Notes 8 Oct 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 500m 19 NAMED
Latham & Watkins Advises Spectrum Equity on Growth Investment in Symmetric Health Solutions 7 Oct 2026
Venture Capital & Growth Healthcare & Life Sciences Latham & Watkins LLP 16 NAMED
DLA Piper advises EliseAI on capital raise at US$4 billion valuation 7 Oct 2026
Venture Capital & Growth Technology DLA Piper USD 350m 7 NAMED
Latham & Watkins Advises Tactacam on Completed Acquisition by GTCR 1 Oct 2026
Private Equity & Buyouts Technology Latham & Watkins LLP 24 NAMED
Latham & Watkins Advises on ADARx Pharmaceuticals’ Upsized US$446.3 Million Initial Public Offering 28 Sept 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 446m 17 NAMED
Latham Advises on Viking Therapeutics’ Upsized US$500 Million Offering of Common Stock and Convertible Senior Notes 25 Sept 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 500m 4 NAMED
Latham & Watkins Represents Sandals Resorts in Landmark Partnership With Royal Caribbean 24 Sept 2026
M&A Hospitality & Leisure Latham & Watkins LLP USD 3bn 38 NAMED
Latham & Watkins Advises on Vaderis Therapeutics’ US$152 Million Series B Financing 24 Sept 2026
Venture Capital & Growth Healthcare & Life Sciences Latham & Watkins LLP USD 152m 16 NAMED
Latham & Watkins Advises Flexpoint Ford in Acquisition of Podium Entertainment 24 Sept 2026
M&A Consumer & Retail Latham & Watkins LLP 23 NAMED
Latham & Watkins Advises on Seminole Tribe of Florida’s Offering of US$1.75 Billion of Senior Secured Gaming Administration Notes 24 Sept 2026
Capital Markets & IPO Financial Services Latham & Watkins LLP USD 1.75bn 6 NAMED
Latham Advises Plains All American Pipeline on US$585 Million Acquisition of Powder River Basin Assets From Silver Creek Midstream 21 Sept 2026
M&A Energy Latham & Watkins LLP USD 585m 27 NAMED
Latham & Watkins Advises on Electra Therapeutics’ Upsized US$350 Million Initial Public Offering 21 Sept 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 350m 14 NAMED
Latham & Watkins Advises Wonder on Its Strategic Partnership With DoorDash 17 Sept 2026
M&A Technology Latham & Watkins LLP 30 NAMED
Latham & Watkins Advises Wynn Resorts on US$900 Million Senior Notes Offering 17 Sept 2026
Debt Capital Markets Latham & Watkins LLP USD 900m 7 NAMED
Latham & Watkins Advises Nestlé on US$1 Billion Sale of Holistic Health Portfolio to Yellow Wood 3 Sept 2026
M&A Consumer & Retail Latham & Watkins LLP USD 1bn 6 NAMED
Latham Represents ONEOK on US$4.425 Billion Acquisition of Brazos Midstream 1 Sept 2026
M&A Energy Latham & Watkins LLP USD 4.42bn 36 NAMED
Latham Advises DAZN on Acquisitions of EverPass Media and ViewLift 28 Aug 2026
M&A Technology Latham & Watkins LLP 53 NAMED
Latham & Watkins Advises on Oversubscribed US$150 Million Private Placement in Connection With Werewolf Therapeutics and Ambros Therapeutics’ Reverse Merger Transaction 24 Aug 2026
Venture Capital & Growth Healthcare & Life Sciences Latham & Watkins LLP USD 150m 3 NAMED
Latham Advises Gossamer Bio on Up to US$250 Million Structured Private Placement, Including US$150 Million of Committed Capital 21 Aug 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 250m 4 NAMED
Latham & Watkins Represented Cox Communications in Completed Combination With Charter Communications 21 Aug 2026
M&A Telecoms & Media Latham & Watkins LLP 39 NAMED
Latham & Watkins Advises Veritas Capital on US$1.1 Billion Sale of Epiq Solutions to TTM Technologies 19 Aug 2026
M&A Technology Latham & Watkins LLP USD 1.10bn 28 NAMED
Latham Advises Frazier Life Sciences on Private Placement Financing in Connection With Fulcrum Therapeutics and Slate Medicines Merger 18 Aug 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP USD 245m 2 NAMED
DLA Piper advises Monaco Enterprises on its US$120 million acquisition by Perimeter Solutions 15 Aug 2026
M&A DLA Piper USD 120m 9 NAMED
Latham & Watkins Advises Kard Financial on Acquisition by Citi 15 Aug 2026
M&A Financial Services Latham & Watkins LLP 16 NAMED
Latham & Watkins Advises The Farmer’s Dog in Acquisition of Woof 10 Aug 2026
M&A Consumer & Retail Latham & Watkins LLP 22 NAMED
Latham & Watkins Advises on BlossomHill Therapeutics’ Upsized US$150 Million IPO 10 Aug 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 150m 16 NAMED
Latham & Watkins Advises Sequoia Capital on Valar Atomics’ US$1 Billion Series B Financing 6 Aug 2026
Venture Capital & Growth Energy Latham & Watkins LLP USD 1bn 5 NAMED
Latham & Watkins Advises CordenPharma on Acquisition of AmbioPharm 4 Aug 2026
M&A Healthcare & Life Sciences Latham & Watkins LLP 35 NAMED
Latham Advises on Scribe Therapeutics’ US$155.51 Million IPO 28 Jul 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 156m 16 NAMED
Latham & Watkins Advises Glenfarne on US$500 Million Investment in Texas LNG by HPS Investment Partners 27 Jul 2026
Project Finance Energy Latham & Watkins LLP USD 500m 19 NAMED
Latham Advises Crusoe on Partnership With ON.energy to Power AI infrastructure 24 Jul 2026
Joint Venture Energy Latham & Watkins LLP 13 NAMED
DLA Piper advises Kira Pharmaceuticals on merger with Jasper Therapeutics 23 Jul 2026
M&A Healthcare & Life Sciences DLA Piper USD 132m 8 NAMED
DLA Piper advises on real estate financing for Public Storage’s US$10.5 billion acquisition of National Storage Affiliates 23 Jul 2026
Real Estate Real Estate DLA Piper USD 10.5bn 3 NAMED
Latham Advises Crystalys Therapeutics on US$130 Million Series B Financing 23 Jul 2026
Venture Capital & Growth Healthcare & Life Sciences Latham & Watkins LLP USD 130m 4 NAMED
Latham & Watkins Advises Erasca on US$550 Million Upsized Public Offering of Common Stock 15 Jul 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 550m 5 NAMED
Latham Advises Carlyle on Sale of Copia Power to EQT 13 Jul 2026
M&A Energy Latham & Watkins LLP 40 NAMED
Latham & Watkins Advises SK Capital Partners on Sale of Milestone Environmental to I Squared Capital 8 Jul 2026
M&A Energy Latham & Watkins LLPLatham & Watkins LLP 35 NAMED
DLA Piper advises Andreessen Horowitz on US$30 million investment in Prosper AI 30 Jun 2026
Venture Capital & Growth Healthcare & Life Sciences DLA Piper USD 30m 5 NAMED
DLA Piper advises Cantor Fitzgerald on Gossamer Bio’s exchange offer and consent solicitation 30 Jun 2026
Capital Markets & IPO Healthcare & Life Sciences DLA Piper USD 72m 12 NAMED
Latham & Watkins Advises NextDecade in US$3.5 Billion Rio Grande LNG Senior Secured Notes Offering 30 Jun 2026
Debt Capital Markets Energy Latham & Watkins LLP USD 3.50bn 17 NAMED
Latham & Watkins Advises Sony Pictures Entertainment in US$100 Million Strategic Investment in Cosm 30 Jun 2026
Venture Capital & Growth Technology Latham & Watkins LLP USD 100m 15 NAMED
Latham Advises on RQ Bio’s US$115 Million Series A Financing 30 Jun 2026
Venture Capital & Growth Healthcare & Life Sciences Latham & Watkins LLP USD 115m 10 NAMED
Latham Advises Agility Robotics on US$2.5 Billion Merger With Churchill Capital Corp XI 25 Jun 2026
M&A Technology Latham & Watkins LLP USD 2.50bn 21 NAMED
Latham & Watkins Advises cAMPfield on US$180 Million Series A 19 Jun 2026
Venture Capital & Growth Healthcare & Life Sciences Latham & Watkins LLP USD 180m 4 NAMED
Latham & Watkins Advises on Dawn Aerospace’s US$25 Million Series B 19 Jun 2026
Venture Capital & Growth Technology Latham & Watkins LLP USD 25m 1 NAMED
Latham & Watkins Advises on US$7 Billion Equity and Equity‑Linked Financing Transactions for Supermicro 12 Jun 2026
Capital Markets & IPO Technology Latham & Watkins LLP USD 7bn 25 NAMED
Latham & Watkins Advises IDEAYA Biosciences on US$300 Million Offering of Common Stock and Pre‑Funded Warrants 11 Jun 2026
Capital Markets & IPO Healthcare & Life Sciences Latham & Watkins LLP USD 300m 14 NAMED
Sidley Represents Equity Group Investments on Exit of Its Investment in CBX to Grupo Aeroportuario del Pacífico in US$2.2 Billion Transaction 8 Jun 2026
M&A Sidley USD 2.20bn 3 NAMED
DLA Piper advises GigCapital7 Corp. on closing of business combination with Hadron Energy 8 Jun 2026
Capital Markets & IPO Energy DLA Piper USD 766m 7 NAMED

SEE ALL 283